Fate Therapeutics, Inc. (FATE) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Fate Therapeutics, Inc. (FATE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $248.2M, listed on NASDAQ, employing roughly 181 people, carrying a beta of 2.14 to the broader market. Fate Therapeutics, Inc. Led by Bahram Valamehr, public since 2013-10-01.
Snapshot as of May 15, 2026.
- Spot Price
- $1.75
- Total OI
- 10.8K